Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Leuk Lymphoma ; 63(6): 1445-1454, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-35125047

RESUMO

In this study, oxidative stress marker (malondialdehyde, MDA) and antioxidant enzymes (glutathione (GSH), catalase (CAT)) levels in the liver and pancreas tissue and the histopathological effects of N-acetylcysteine (NAC) were investigated in l-asparaginase (l-ASP) induced liver and pancreatic damage in rats. Forty male albino rats were divided into four groups. The control group was intraperitoneally injected physiological saline (0.02 mL/g); NAC group was injected NAC (200 mg/kg, five days); l-ASP group was injected single-dose l-ASP (10,000 U/kg), and l-ASP + NAC group was injected NAC for five days following single-dose l-ASP (10,000 U/kg). The surgical operation was performed on all animals on the fifth day. There was no difference between the groups regarding tissue MDA, GSH, and CAT levels (p>.05, for all). In the group receiving NAC after l-ASP, there was a significant improvement in the liver and pancreas damage score than the l-ASP group. NAC was effective in reducing organ damage caused by l-ASP.


Assuntos
Acetilcisteína , Asparaginase , Acetilcisteína/metabolismo , Acetilcisteína/farmacologia , Animais , Asparaginase/farmacologia , Glutationa/metabolismo , Glutationa/farmacologia , Humanos , Fígado , Masculino , Estresse Oxidativo , Pâncreas/metabolismo , Ratos , Ratos Wistar
2.
Jpn J Infect Dis ; 74(4): 273-279, 2021 Jul 21.
Artigo em Inglês | MEDLINE | ID: mdl-33250495

RESUMO

Little is known about the therapeutic use of hydroxychloroquine in pediatric patients with coronavirus disease 2019 (COVID-19). Here, we retrospectively retrieved data of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR-positive pediatric patients from 20 hospitals in 8 Turkish cities. We obtained epidemiological, clinical, and laboratory features of the patients, as well as the drugs used for treating COVID-19. A total of 237 nasopharyngeal swab SARS-CoV-2 PCR-positive children were included in the study from March 26, 2020 to June 20, 2020. The mean age of asymptomatic children (118 ± 62 months) was higher than that of symptomatic children (89 ± 69 months). Symptomatic children had significantly lower mean lymphocyte counts and higher mean CRP, D-dimer, procalcitonin, and LDH levels than asymptomatic children in the univariate analysis. Among 156 children, 78 (50%), 15, 44, and 21 were treated with a hydroxychloroquine-containing regimen, hydroxychloroquine + azithromycin + oseltamivir, hydroxychloroquine + azithromycin, and hydroxychloroquine alone, respectively. Among 156 patients who received medical treatment, 90 (58%) underwent pre- and/or post-treatment electrocardiogram (ECG). However, none of them had ECG abnormalities or required hydroxychloroquine discontinuation due to adverse drug reactions.


Assuntos
Antivirais/uso terapêutico , Tratamento Farmacológico da COVID-19 , Pandemias/prevenção & controle , SARS-CoV-2/efeitos dos fármacos , Adolescente , Infecções Assintomáticas , Criança , Pré-Escolar , Eletrocardiografia , Feminino , Humanos , Hidroxicloroquina/uso terapêutico , Lactente , Recém-Nascido , Laboratórios , Contagem de Linfócitos/métodos , Masculino , Estudos Retrospectivos , Turquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA